Latest Corporate News
Boston Scientific Acquires Penumbra for $14.5 Billion
Boston Scientific entered a merger agreement on January 15, 2026, to acquire medtech firm Penumbra in a $14.5 billion deal, expanding its neurovascular portfolio. This acquisition aims to strengthen Boston Scientific's position in the medical technology sector.
The deal highlights ongoing consolidation in healthcare medtech.
Worthington Steel Completes Kloeckner Takeover
Worthington Steel successfully entered a business combination agreement with Kloeckner & Co on January 15, creating a $9.5 billion revenue North American steel service center giant. The merger promises $150 million in annual synergies, tripling Worthington's scale while maintaining strong margins.
It follows intense M&A activity in the steel industry.
Repare Therapeutics Shareholders Approve XenoTherapeutics Acquisition
Repare shareholders approved the acquisition by XenoTherapeutics with 99.76% support at a special meeting on January 19, 2026. The deal awaits court approval on January 23, with closing expected by January 28.
This bolsters precision oncology capabilities for the acquirer.
Goldman Sachs Shares Surge on Record Equity Trading Revenue
Goldman Sachs shares rose 4.6% after reporting the highest equity trading revenue among Wall Street banks, driving strong banking sector results. Major banks showed robust performance buoyed by trading revenues despite some divergences.
Investor focus remains on individual bank report cards.
TSMC Reports 25.5% YoY Revenue Growth, Raises AI Margin Guidance
Taiwan Semiconductor Manufacturing Company delivered 25.5% year-on-year Q4 revenue growth and raised long-term gross margin guidance above 56%. Results alleviate concerns over AI demand sustainability in tech sector.
TSMC's performance supported broader technology gains.
Japan Steel Works Resolves Subsidiary Absorption-Type Merger
Japan Steel Works approved an absorption-type merger of wholly-owned subsidiary M&E on January 19, 2026, effective April 1. Aims to integrate functions amid challenging business environment post-2020 reorganization.
Follows policy decision from April 2025.